Skip to main content
. 2014 Sep 27;31(10):1059–1071. doi: 10.1007/s12325-014-0155-3

Fig. 2.

Fig. 2

Comparison of mean itch scores at baseline and 16 h after treatment instillation at 3 min post-conjunctival allergen challenge (primary endpoint). Mean itch scores for alcaftadine 0.25%, olopatadine 0.2%, and placebo. *P < 0.0001 for alcaftadine and olopatadine versus placebo; **P = 0.0006 for alcaftadine versus olopatadine. P values calculated using the two-sample t test